» Authors » Jeffrey O Hollinger

Jeffrey O Hollinger

Explore the profile of Jeffrey O Hollinger including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 66
Citations 1508
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Hsu E, Liu S, Shrivats A, Watt A, McBride S, Averick S, et al.
J Biomed Nanotechnol . 2014 Apr; 10(6):1130-6. PMID: 24749407
The endogenous RNA interference (RNAi) pathway enables control of pathologies caused by the dysregulation of proteins. Several biological molecules are active in RNAi including short interfering ribonucleic acid (siRNA). The...
12.
Hsu C, Liu S, Hsu E, Hollinger J
J Biomed Mater Res A . 2013 Nov; 102(11):4037-43. PMID: 24288199
Intracellular protein delivery is a novel tool for functional analysis of protein inside a cell. Several protein delivery reagents with diverse mechanisms have been developed and are commercially available. In...
13.
Shrivats A, Hollinger J
Methods Mol Biol . 2013 Oct; 1202:149-60. PMID: 24155228
RNA interference (RNAi) is a powerful tool being used to develop therapies for pathologies caused by gene overexpression. Heterotopic ossification pathologies such as trauma-induced heterotopic ossification and fibrodysplasia ossificans progressiva...
14.
Perrien D, Young C, Alvarez-Urena P, Dean D, Lynch S, Hollinger J
Spine J . 2013 Apr; 13(5):580-6. PMID: 23541446
Background Context: Recombinant human platelet-derived growth factor-BB (rhPDGF-BB) homodimer is a chemotactic, mitogenic, and angiogenic factor expressed by platelets. This biological triad is profoundly important in the bone regenerative cascade....
15.
Averick S, Paredes E, Irastorza A, Shrivats A, Srinivasan A, Siegwart D, et al.
Biomacromolecules . 2012 Sep; 13(11):3445-9. PMID: 22967138
Cationic nanogels with site-selected functionality were designed for the delivery of nucleic acid payloads targeting numerous therapeutic applications. Functional cationic nanogels containing quaternized 2-(dimethylamino)ethyl methacrylate and a cross-linker with reducible...
16.
Shah V, Bendele A, Dines J, Kestler H, Hollinger J, Chahine N, et al.
J Orthop Res . 2012 Aug; 31(3):413-20. PMID: 22933269
The purpose of this study was to assess whether intra-tendon delivery of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) would improve Achilles tendon repair in a rat collagenase-induced tendinopathy model. Seven...
17.
Gruskin E, Doll B, Futrell F, Schmitz J, Hollinger J
Adv Drug Deliv Rev . 2012 Jun; 64(12):1063-77. PMID: 22728914
Demineralized bone matrix (DBM) is an osteoconductive and osteoinductive commercial biomaterial and approved medical device used in bone defects with a long track record of clinical use in diverse forms....
18.
Kim J, Hollinger J
Biomed Mater . 2012 Jun; 7(4):045008. PMID: 22652428
The purposes of this study were to determine the pharmacokinetics of recombinant human bone morphogenetic protein-2 (rhBMP-2) from a polyurethane (PUR)-based porous scaffold and to determine the biological responses of...
19.
Kim J, McBride S, Tellis B, Alvarez-Urena P, Song Y, Dean D, et al.
Biofabrication . 2012 Mar; 4(2):025003. PMID: 22427485
Bone tissue engineering scaffolds composed of poly(d,l-lactide:glycolide) (DL-PLGA) and β-tricalcium phosphate (β-TCP) nanocomposites were prepared and characterized. Scaffolds with two specific architectures were produced via fused deposition modeling (FDM), a...
20.
Alvarez P, Hee C, Solchaga L, Snel L, Kestler H, Lynch S, et al.
J Craniofac Surg . 2012 Feb; 23(1):20-9. PMID: 22337369
The specialty of craniofacial surgery is broad and includes trauma, aesthetics, reconstruction of congenital deformities, and regeneration of tissues. Moreover, craniofacial surgery deals with a diverse range of tissues including...